BMRA
Price
$3.16
Change
+$0.01 (+0.32%)
Updated
Jun 30, 04:41 PM (EDT)
Capitalization
14M
GKOS
Price
$103.33
Change
+$1.91 (+1.88%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
4.61B
30 days until earnings call
Interact to see
Advertisement

BMRA vs GKOS

Header iconBMRA vs GKOS Comparison
Open Charts BMRA vs GKOSBanner chart's image
Biomerica
Price$3.16
Change+$0.01 (+0.32%)
Volume$100
Capitalization14M
Glaukos
Price$103.33
Change+$1.91 (+1.88%)
Volume$8.54K
Capitalization4.61B
BMRA vs GKOS Comparison Chart in %
Loading...
BMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRA vs. GKOS commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRA is a Buy and GKOS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (BMRA: $3.15 vs. GKOS: $101.42)
Brand notoriety: BMRA and GKOS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BMRA: 27% vs. GKOS: 196%
Market capitalization -- BMRA: $14M vs. GKOS: $4.61B
BMRA [@Medical Specialties] is valued at $14M. GKOS’s [@Medical Specialties] market capitalization is $4.61B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRA’s FA Score shows that 0 FA rating(s) are green whileGKOS’s FA Score has 0 green FA rating(s).

  • BMRA’s FA Score: 0 green, 5 red.
  • GKOS’s FA Score: 0 green, 5 red.
According to our system of comparison, GKOS is a better buy in the long-term than BMRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRA’s TA Score shows that 5 TA indicator(s) are bullish while GKOS’s TA Score has 6 bullish TA indicator(s).

  • BMRA’s TA Score: 5 bullish, 4 bearish.
  • GKOS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, GKOS is a better buy in the short-term than BMRA.

Price Growth

BMRA (@Medical Specialties) experienced а -0.32% price change this week, while GKOS (@Medical Specialties) price change was +1.27% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.51%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was +2.89%.

Reported Earning Dates

GKOS is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+2.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GKOS($4.61B) has a higher market cap than BMRA($14M). BMRA YTD gains are higher at: 31.206 vs. GKOS (-32.360). BMRA has higher annual earnings (EBITDA): -5.97M vs. GKOS (-82.12M). GKOS has more cash in the bank: 295M vs. BMRA (7.13M). BMRA has less debt than GKOS: BMRA (937K) vs GKOS (384M). GKOS has higher revenues than BMRA: GKOS (315M) vs BMRA (5.5M).
BMRAGKOSBMRA / GKOS
Capitalization14M4.61B0%
EBITDA-5.97M-82.12M7%
Gain YTD31.206-32.360-96%
P/E RatioN/AN/A-
Revenue5.5M315M2%
Total Cash7.13M295M2%
Total Debt937K384M0%
FUNDAMENTALS RATINGS
BMRA vs GKOS: Fundamental Ratings
BMRA
GKOS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
10049
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
6161
P/E GROWTH RATING
1..100
10064
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRA's Valuation (34) in the Medical Specialties industry is somewhat better than the same rating for GKOS (93). This means that BMRA’s stock grew somewhat faster than GKOS’s over the last 12 months.

GKOS's Profit vs Risk Rating (49) in the Medical Specialties industry is somewhat better than the same rating for BMRA (100). This means that GKOS’s stock grew somewhat faster than BMRA’s over the last 12 months.

GKOS's SMR Rating (94) in the Medical Specialties industry is in the same range as BMRA (98). This means that GKOS’s stock grew similarly to BMRA’s over the last 12 months.

GKOS's Price Growth Rating (61) in the Medical Specialties industry is in the same range as BMRA (61). This means that GKOS’s stock grew similarly to BMRA’s over the last 12 months.

GKOS's P/E Growth Rating (64) in the Medical Specialties industry is somewhat better than the same rating for BMRA (100). This means that GKOS’s stock grew somewhat faster than BMRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRAGKOS
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
64%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 21 days ago
80%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 18 days ago
84%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
60%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WOR63.810.74
+1.17%
Worthington Enterprises
TOMZ1.050.01
+0.96%
TOMI Environmental Solutions
EFXT7.810.04
+0.51%
Enerflex Ltd
DTE131.620.06
+0.05%
DTE Energy Company
RAPT8.43-1.30
-13.36%
RAPT Therapeutics Inc

BMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRA has been loosely correlated with ZIMV. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRA jumps, then ZIMV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRA
1D Price
Change %
BMRA100%
-1.56%
ZIMV - BMRA
39%
Loosely correlated
+2.89%
LFWD - BMRA
29%
Poorly correlated
+15.16%
SENS - BMRA
27%
Poorly correlated
-1.18%
CALZF - BMRA
26%
Poorly correlated
N/A
GKOS - BMRA
24%
Poorly correlated
+0.36%
More

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ITGR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
+0.36%
ITGR - GKOS
49%
Loosely correlated
+0.57%
ISRG - GKOS
49%
Loosely correlated
-0.09%
RDNT - GKOS
48%
Loosely correlated
-1.60%
NTRA - GKOS
48%
Loosely correlated
-0.12%
TWST - GKOS
45%
Loosely correlated
-2.73%
More